U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07083609) titled 'Treatment Outcomes of Direct Oral Anticoagulants in Cerebral Venous Thrombosis in Vietnam' on July 07.
Brief Summary: This prospective, single-arm observational cohort study aims to evaluate the real-world effectiveness and safety of direct oral anticoagulants (DOACs), specifically dabigatran or rivaroxaban, in patients with cerebral venous thrombosis (CVT). The study will be conducted at Bach Mai Hospital, a national tertiary stroke referral center in Hanoi, Vietnam.
A minimum of 69 adults with radiologically confirmed CVT will be enrolled between June 2025 and June 2027. All participants must have received therapeutic-dose hepari...